BAP Officer Details

Meetings Secretary

Professor Mitul Mehta

Mitul Mehta

King's College, University of London
Meetings Secretary until 2020

My research is focussed around the use of neuroimaging to help understand both how to measure drug effects on the brain and what these effects might look like. I am a Reader in Imaging and Psychopharmacology and head up the Neuropharmacology group in the Department of Neuroimaging at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London. Here, we look at acquisition methods and application of the latest analysis techniques, as well as working closely with industry to gain insights into novel compounds and mechanisms. Before this, I was based at Hammersmith Hospital where I trained in utilising PET imaging to understand the links between cognition and psychopharmacology.

It was in fact psychopharmacology that attracted me to do a PhD (1996-2000) in the University of Cambridge and at that time the amount of research into dopaminergic modulation of cognitive function in humans was limited. This formed the basis of my doctoral work and included a small PET experiment, which sparked my interest in neuroimaging methods. I was fortunate to receive the BAP Vernalis Prize in 2005 in relation to this work.

The BAP provides a great forum for those interested psychopharmacology and attendance at the summer meeting is always enjoyable and informative. I look forward to seeing you at the next one!

Declaration of Interests

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No
  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No
  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No
  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. Acted as an advisory Board Member for Lundbeck on one programme
  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No
  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. Lundbeck (investigator initiated grant), Takeda (clinical trial)
  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No
  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No
  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No
  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No
  21. If there is anything else you feel it necessary to disclose, please provide details below:

Form completed on 31st July 2019